Work

Ofatumumab As Initial Therapy For Indolent B Cell Lymphomas: A Phase II Trial

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.3062.3062

Authors: Jeffrey A. Barnes, Yang Feng, Ephraim P Hochberg, Tak Takvorian, James Weitzman, David C. Fisher, Eric D. Jacobsen, Robin Joyce, Donna S. Neuberg, Jeremy S. Abramson

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2981290030

FWCI: 0.223

Cites:

Cited by: 2

Related to: 10